Product Information
MAVYRET 100-40 MG TABLET is a brand product labeled by AbbVie Inc., priced at $152.9239 per EA under NDC 00074262584. Its NADAC has been published 210 times since Aug 17, 2022.
FDA first approved this application on Aug 3, 2017.
Strength
100; 40 mg/1; mg/1
Manufacturer
AbbVie Inc.NDC
00074262584
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLECAPREVIR; PIBRENTASVIRApproval Type
New Drug (NDA)
FDA Application
NDA209394FDA Approved
8/3/2017
On Market Since
8/3/2017
Pharmacological Classes
Price Statistics
The NADAC for MAVYRET 100-40 MG TABLET has been published 210 times since Aug 17, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $152.9239 per EA |
|---|---|
| All-time high | $153.0769 (Jun 10, 2026) |
| All-time low | $152.4200 (Jul 17, 2024) |
| 52-week high | $153.0769 |
| 52-week low | $152.8048 |
| Median price | $152.7900 |
| Average price | $152.7606 |
| Largest weekly change | +0.2% (Sep 18, 2024) |
| Weeks tracked | 210 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MAVYRET 100-40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MAVYRET 100-40 MG TABLET, manufactured by AbbVie Inc., is $152.9239 per EA (NDC 00074262584), effective Aug 19, 2026.
How has the price of MAVYRET 100-40 MG TABLET changed over time?
Over the history we have for it, the NADAC for MAVYRET 100-40 MG TABLET has held within roughly two percent of its current level. It has been tracked across 210 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for MAVYRET 100-40 MG TABLET?
Since Aug 17, 2022, the NADAC for MAVYRET 100-40 MG TABLET has ranged from a low of $152.4200 (Jul 17, 2024) to a high of $153.0769 (Jun 10, 2026), with a median of $152.7900 per EA.
Are there cheaper alternatives to MAVYRET 100-40 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MAVYRET 100-40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MAVYRET 100-40 MG TABLET?
MAVYRET 100-40 MG TABLET (NDC 00074262584) is labeled by AbbVie Inc., and CMS classifies it as a brand product.